MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-13-0003675
Fibovil Pharmaceuticals Private Limited - pharma in Panchkula, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹36.82 Cr
▲ 22% YoY
Net profit · FY 2025
₹2.07 Cr
Net margin 5.6%
EBITDA · FY 2025
₹4.31 Cr
EBITDA margin 11.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹2 Cr
Satisfied ₹3 Cr
Company age
7 yrs
Est. 2019
Employees · EPFO
25
Provident fund records
About Fibovil Pharmaceuticals Private Limited
Data last updated:
Fibovil Pharmaceuticals Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24239HR2019PTC079733. Its GSTIN is 06AADCF7074R1ZZ (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Jagat Parkash and Sahil.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shed No 276 Industrial Area Phase – II, Panchkula, Haryana, India – 134113.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.82 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹2.07 Cr (net margin 5.6%) and EBITDA of ₹4.31 Cr (EBITDA margin 11.7%). Revenue has grown at a compounded annual rate (CAGR) of 41% over three years and 67% over five years.
The company has about 25 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Fibovil. As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹3 Cr on record. Court records list 12 cases involving the company, including 5 filed by the company and 7 filed against it; 9 cases are pending.
Fibovil Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0003675). For more details, the company can be reached via its website fibovil.com.
Company details
CIN U24239HR2019PTC079733
Registration Number 079733
Incorporation Date 12 April 2019
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-HR-13-0003675
Recognitions & Rankings of Fibovil Pharmaceuticals
Contact details
Fibovil Pharmaceuticals Private Limited's registered office is in Panchkula, Haryana. Its website is fibovil.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressShed No 276 Industrial Area Phase – II, Panchkula, Haryana, India – 134113
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Fibovil Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Fibovil Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Fibovil Pharmaceuticals operates one associated brand: Fibovil. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and franchise services in India. | fibovil.com |
Financials of Fibovil Pharmaceuticals Private Limited
FY 2025 filings availableFibovil Pharmaceuticals Private Limited reported revenue of ₹36.82 Cr (up 22% YoY) for FY 2025.
Revenue · FY 2025
₹36.82 Cr ▲ 22%
Net profit · FY 2025
₹2.07 Cr margin 5.6%
EBITDA · FY 2025
₹4.31 Cr margin 11.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 41%
5 years · compounded
▲ 67%
EBITDA CAGR growth
1 year
▲ 106%
3 years · compounded
▲ 92%
5 years · compounded
▲ 144%
Revenue has grown at a compounded annual rate (CAGR) of 67% over five years, including 22% growth in the latest year. EBITDA rose 106% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹36.82 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.31 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.07 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.7% | ||||
| Net Profit Margin | 5.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fibovil Pharmaceuticals Private Limited, buy the company report.
Board of directors of Fibovil Pharmaceuticals Private Limited
Fibovil Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jagat Parkash Also directs: Cafoli Lifecare Private Limited | Director | 20 Jun 2022 | 4 Years 4 Months | Current |
| Sahil Also directs: Emfica Pharmaceuticals Private Limited | Director | 12 Apr 2019 | 7 Years 6 Months | Current |
| Reetu Rani Also directs: Cafoli Lifecare Private Limited | Director | 12 Apr 2019 | 7 Years 6 Months | Current |
Auditor
Fibovil Pharmaceuticals Private Limited is audited by S ASHISH & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S ASHISH & CO. | FY 2024 | 010440C |
Shareholding
The shareholding of Fibovil Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Fibovil Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2 Cr
Satisfied charges
₹3 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Feb 2023 | 100721226 | Others | ₹2 Cr | Open | |
| 23 Apr 2024 | 100918402 | Others | ₹3 Cr | Satisfied |
To see the full charge records of Fibovil Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Fibovil Pharmaceuticals Private Limited has 12 court cases on record: 5 filed by Fibovil Pharmaceuticals, 7 filed against it. 9 cases are pending and 3 are disposed.
Total cases
12
Filed by the company
5
Filed against the company
7
Pending
9
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 2 | 3 |
| High courts | 6 | 5 | 6 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
| Bombay High Court | Court case (LPETN) | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
| Bombay High Court | Court case (CRR) | Filed against the company by Sun Pharmaceutical Industries Limited and Anr. | Pending |
| High Court | Court case (COMIP) | Filed against the company by Franco-Indian Pharmaceuticals Private Limited | Pending |
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Franco-Indian Pharmaceuticals Private Limited | Pending |
To see the full case history of Fibovil Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fibovil Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Fibovil Pharmaceuticals Private Limited has a workforce of 25 employees on its EPFO records as of Feb 15, 2026, across 1 active EPFO establishment.
Employee count
25
Active EPFO establishments
1
GST
Fibovil Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AADCF7074R1ZZ | Haryana | Active | 02 May 2019 |
To see the full GST registrations and return filing status of Fibovil Pharmaceuticals Private Limited, buy the company report.
Recent activity
Fibovil Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Jagat Parkash was appointed as Director on 20 Jun 2022.
Charges
A charge registered on 23 Apr 2024 via Charge ID 100918402 with Others was fully satisfied on 03 Jan 2026.
AGM
Fibovil Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Fibovil Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Charges
A charge with Others amounted to Rs. 300.00 Lakh with Charge ID 100918402 was registered on 23 Apr 2024.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 100721226 was registered on 08 Feb 2023.
Appointed
Jagat Parkash was appointed as Director.
Appointed
Reetu Rani was appointed as Director.
Appointed
Sahil was appointed as Director.
Incorporation
12 Apr 2019
Fibovil Pharmaceuticals Private Limited was registered on 12 Apr 2019 with Roc Haryana & aged 7 years 6 months as per MCA records.
Frequently asked questions
Fibovil Pharmaceuticals is an active private limited company based in Panchkula, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 April 2019 (7+ years old) and is registered under CIN U24239HR2019PTC079733.
Fibovil Pharmaceuticals has 3 current directors:
- Jagat Parkash - Director
- Sahil - Director
- Reetu Rani - Director
The latest financial statements of Fibovil Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Fibovil Pharmaceuticals is 06AADCF7074R1ZZ, registered in Haryana.
The CIN (Corporate Identification Number) of Fibovil Pharmaceuticals is U24239HR2019PTC079733. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fibovil Pharmaceuticals has 12 court cases on record: 5 filed by the company and 7 filed against it. 9 are pending. Most are in the district courts.
Fibovil Pharmaceuticals was incorporated on 12 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Haryana.
Jagat Parkash was appointed as Director on 20 Jun 2022. Reetu Rani was appointed as Director on 12 Apr 2019. Sahil was appointed as Director on 12 Apr 2019.
Yes, Fibovil Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HR-13-0003675).
Fibovil Pharmaceuticals can be reached through the website fibovil.com. Its registered office is in Panchkula, Haryana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages